scholarly journals Serologic Concentrations of HER-2/neu in Breast Cancer Patients with Visceral Metastases Receiving Trastuzumab Therapy Predict the Clinical Course

2002 ◽  
Vol 48 (8) ◽  
pp. 1360-1362 ◽  
Author(s):  
Thomas Schöndorf ◽  
Markus Hoopmann ◽  
Mathias Warm ◽  
Rainer Neumann ◽  
Anke Thomas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Clinical Course ◽  
Breast Cancer Patients ◽  
Trastuzumab Therapy ◽  
Visceral Metastases ◽  
Her 2

Chromosome 17 polysomy and Her-2/neu status in metastatic breast cancer patients indicated to trastuzumab therapy

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 9584-9584 ◽  
Author(s):  
M. Hajduch ◽  
R. Trojanec ◽  
K. Bouchalova ◽  
Z. Kolar ◽  
K. Petrakova ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Metastatic Breast ◽  
Chromosome 17 ◽  
Breast Cancer Patients ◽  
Trastuzumab Therapy ◽  
Her 2

scholarly journals MicroRNA-26a-5p as a potential predictive factor for determining the effectiveness of trastuzumab therapy in HER-2 positive breast cancer patients

BioMedicine ◽  
2021 ◽  
Vol 11 (2) ◽  
Author(s):  
Sadra Samavarchi Tehrani ◽  
Ehsan Zaboli ◽  
Farzin Sadeghi ◽  
Soraya Khafri ◽  
Ansar Karimian ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Predictive Factor ◽  
Breast Cancer Patients ◽  
Trastuzumab Therapy ◽  
Her 2 ◽  
Positive Breast Cancer

Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy

2021 ◽  
Author(s):  
Leisha C. Elmore ◽  
Henry M. Kuerer ◽  
Carlos H. Barcenas ◽  
Benjamin D. Smith ◽  
Makesha V. Miggins ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Systemic Therapy ◽  
Clinical Course ◽  
Breast Cancer Patients ◽  
Neoadjuvant Systemic Therapy
Sign in / Sign up

Export Citation Format

Share Document